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INTRODUCTION
Patient safety is one of the most essential elements of modern-day 
health-care systems [1]. With the mounting reliance on medication 
therapy as the primary intervention for most illnesses, medications 
may also cause either non-preventable adverse effects or potentially 
preventable medications errors [1,2]. Adverse drug reactions (ADRs) 
are common causes of mortality and morbidity worldwide, and its 
occurrence in real-world medical practice cannot always be predicted 
by pre-marketing data given that a limited number of selected patients 
are enrolled in clinical trials for specific indications and monitored for a 
limited period of time [3]. Various studies in general adult populations 
have quantified that 5%–7% of all hospitalizations are due to ADRs, 
with over half of these arbitrated to be preventable, and that 3%–6% 
of ADRs are fatal or have serious health consequences [4-6]. Health-
care costs attributable to ADRs have been estimated to be 5%–9% of 
total inpatient costs per annum [7]. Older people experience greater 
morbidity with a corresponding increase in medication utilization, 
resulting in a higher risk of ADRs. The relative physiological change that 
occurs with aging affects the pharmacokinetics and pharmacodynamics 
of medications, which may increase the potential for drug toxicity 
and ADRs [8]. Various definitions are being identified by researchers 
for ADR, for instance, the US FDA definition described it as “any 
adverse event for which there is a reasonable possibility that the drug 
caused the adverse event, ‘reasonable possibility’ suggesting a causal 
relationship between the drug and the adverse event”[9], the World 
Health Organization (WHO) defines it as “a response to a medicine 
which is noxious and unintended, and which occurs at doses normally 
used in man” [10], and as per Edwards and Aronson definition, “ADR 
is an appreciably harmful or unpleasant reaction, resulting from an 
intervention related to the use of a medicinal product, which predicts 
hazard from future administration and warrants prevention or specific 
treatment, or alteration of the dosage regimen, or withdrawal of the 
product”[11].
There are various factors that predispose patients to ADRs such as 
polypharmacy, age, intercurrent diseases, comorbidity, gender, history 
of ADRs, and length of hospital stays [12]. Although few authors have 
explored the relationship between the risk factors and ADRs [13-15], 
there exists a controversial corroboration due to differences in 
definitions, study settings, study designs, study population, statistical 
methods, race, and ethinicity [16]. Few studies explored that female 
gender is the major predictor of adverse reactions [17-20], while other 
findings documented that patients with age above 65 years had more 
than 50% of hospitalizations due to ADRs [5,21].
Even though a large number of studies have identified and assessed 
ADRs, little has been focused on the associated risk factors with 
appropriate statistical analysis in adult and elderly population. This 
review was conducted with the aim to determine potential significant 
risk factors of ADRs during hospitalization in the adult and elderly 
population.
This review was conducted and reported according to the Preferred 
Reporting Items for Systematic Reviews and Meta-Analyses guidelines. 
An electronic search of articles published in English language in 
databases such as Cochrane database of systematic reviews, MEDLINE, 
EMBASE, Scopus, and Google Scholar in between January 2001 and 
April 2018 was conducted. Medical subject heading terminology and 
other keywords were used for studies published in different databases. 
The search terms used were: “Adverse reactions,” “ADRs,” “adverse 
effects,” “drug-related problems,” “risk factors,” “predictive factors,” 
“general adult population,” “elderly patients,” and “hospital admission.” 
The auxiliary search terms used included: “Drug adverse effects,” “drug 
therapy,” “geriatric,” “hospitalization,” and “emergency admissions.” All 
the titles and abstracts of identified studies were examined critically 
for potential relevance. The reference lists of all eligible full-text 
articles were hand searched and reviewed to locate other relevant 
original studies. Two reviewers undertook searches independently 
and assessed and discussed study findings, and the final consensus was 
reached to ensure the search strategy was accurate and reproducible.
All studies that were peer-reviewed, highly citation, available in English 
language, and full-text articles were included. Those studies that 
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reported ADRs either prospectively or retrospectively in hospitalized 
adult and elderly patients were included, irrespective of hospital 
department or specialty. For inclusion in the review, studies had to 
include an explicit definition of what was considered an ADR and/or 
an explicit assessment of causality, as well as a clear description of the 
method used for ADR identification. In particular, studies also had to 
explore factors associated with an increased risk of an ADR statistically 
through logistic regression (univariate and multivariate).
Studies that looked at ADR-related hospital readmissions were excluded 
from the review. Those studies with only abstracts were excluded if the 
full-text article could not be found, as it restricts meaningful evaluation 
and quality appraisal provided in abstracts. Studies and/or clinical 
trials that reported adverse reactions in special population such as 
pediatric and pregnant women and lactating mothers were excluded. 
Those studies that reported ADRs associated with off-labeled drug 
usage were also excluded from the study.
All the titles and abstracts that fulfilled inclusion criteria were assessed 
critically for relevance of title, year of publication, first author, country 
of origin, study sample size, study population, study design, and subject 
age groups. Data were extracted including explicit ADR definition, 
identification method, risk factors, statistical method and prevalence, 
and causality assessment using a custom-designed data extraction form. 
In those studies, where the prevalence was not directly reported, it was 
calculated by dividing the number of patients identified with an ADR of 
all included patients. Extracted data were entered into Microsoft Excel 
365 for descriptive data analysis. Overall mean±standard deviation of 
ADR prevalence was calculated at 95% confidence intervals (CIs).
ADR ASSOCIATED RISK FACTORS - ADULT POPULATION
The risk factors were categorized as patient-related and medication-
related risk factors. Univariate analysis identified very few significant 
medication-related risk factors such as polypharmacy [1,15,22,23], non-
adherence [1], anti-tuberculosis drugs [23], and ART drugs [23]. Whereas 
results of multivariate analysis concluded that polypharmacy [1,15,22,23] 
was the highly influential independent predictor of ADR. Patient-related 
risk factors such as comorbidities, female gender, body mass index, 
h/o ADR, length of hospital stay, impaired renal function, number of 
diagnoses, and dependent living situation were significant [1,15,22,23]. 
Among these, comorbidity was evidenced as independent predictor in 
four studies, followed by h/o ADR and length of hospital stay.
ADR-ASSOCIATED RISK FACTORS - ELDERLY POPULATION
In this assessment of the effect of predictors in the development of 
ADRs, under univariate analysis, patient-related determinants were 
age, female gender, comorbidities, length of hospital stay, renal failure, 
liver disease, dementia, IHD, heart failure, depression, hyperlipidemia, 
and increased serum concentration and the medication-related 
predictors were polypharmacy, number of doses, narrow therapeutic 
drugs, anticholinergic drugs, antiarrhythmics, and antihyperglycemic 
drugs, and inappropriate prescription was significant [25-30]. While 
in the multivariate analysis, age ≥85 years [27], female gender [26], 
and length of hospital stay [29] were patient-related independent 
predictors and polypharmacy was the only one medication-related 
independent predictor identified in four studies, in which polypharmacy 
with ≥8 drugs was observed as the highly influential predictor in two 
studies [28,29] and ≥5 drugs was evidenced in a single study [26].
To the best of our knowledge, this is the first kind of systematic review 
that appraised univariate and multivariate logistic regression in the 
identification of significant risk factors for ADRs. This search found 
only 11 studies that met the inclusion criteria, and nearly half of the 
studies were done in adult population. Studies showed explaining the 
variations in prevalence rates and risk factors of ADRs.
An overall up to 13.7% of patients admitted to hospital experience 
an ADR during their hospitalization, while previously conducted 
systematic review [31] projected that up to 4% of all adult patients 
admitted to hospital experience an ADR either leading to or during their 
hospital admission. However, a meta-analysis conducted by Oscanoal 
et al. [32]., in the year 2017, reported that the prevalence of ADR among 
elderly patients that led to hospital admissions accurately to be 8.7% 
(95% CI, 7.6%–9.8%).
In our review, three unambiguous definitions were being utilized in 
the studies for ADR identification which might explain the differences 
in ADR prevalence rate reported. Previous literatures [33] have 
sufficiently elaborated on the contribution of different fundamental 
criteria adopted in various setting in the identification of ADR between 
reported studies with respect to prevalence. Although one study used 
USFDA definition, there was no significant change in prevalence rate 
reported owing to the slenderest difference compared to the WHO 
definition.
RISK FACTORS OF ADRs
In our review, overall 80 risk factors were studied among the total 
population of 20,974, wherein 30 significant risk factors were 
recognized as potential and 18 as independent predictors of ADRs based 
on univariate and multivariate logistic regression analysis (Table 1).
Polypharmacy
Polypharmacy was the most consistent and highly acknowledged 
predictor witnessed in almost all the literature to quantify the risk 
associated with ADR [1,15,24,26-29,34]. In continuation, few studies 
quoted that polypharmacy is chosen when a patient presents with 
multiple comorbidities in order to augment the initial therapy 
and advanced age of patients who may require drugs with varied 
mechanisms of action [35]. However, polypharmacy intensifies the 
possibility of ADRs due to drug- drug interactions from 2% to 5% [36-
40] and may heighten it up to 9% with each additional prescribed drug 
thereafter [27]. And also, it can increase the risk of multiple ADRs than 
single ADR [41]. It is important for the prescribers to ponder on this 
risk factor, take imperative steps to reduce the risk through usage of 
combinational drugs, or discontinuation of unnecessary drugs through 
reevaluating the disease condition of the patients specifically in older 
adults. Reducing the number of drugs in the prescription is the simplest 
way of reducing the ADRs [42]. Furthermore, the total number of 
drugs along with the individual drug’s risk could be incorporated into 
an electronic algorithm and determining the benefit-to-risk ratio of 
individual drug therapy is essential to minimize polypharmacy.
Comorbidities
Comorbidity was the second most frequently reported significant risk 
factor for ADR in the adult and elderly patients [1,22,23,25,26,28,30]. 
However, three studies particularized through the application of 
multivariate logistic regression to identify it as an independent 
predictor of ADR but then only in adult patients [1,22,23]. Two 
authors expressed renal dysfunction and limited sample size as the 
possible cause of refuting comorbidity as a significant risk factor. 
Patients with polymorbidity may have altered pharmacodynamic 
and pharmacokinetic mechanisms due to drug-disease interaction 
predisposing them to ADRs and other explanations that require further 
research in this area.
Length of hospital stay
ADRs are considered as serious health hazard in hospitalized patients. 
From the findings of the review, significant association was built up 
between the length of hospital stay and ADRs [24,29]. Findings clarified 
that the length of stay is the proxy measure of comorbidity and chronic 
illness with an increased number of prescribed drugs at higher doses, 
reflecting an increased risk of ADR. The probability of adverse reactions 
increases 6% for every additional day of hospitalization [43], and every 
2.2 hospital bed day of patient was due to ADRs [26]. Length of hospital 
stays ≥12 days was 2.3 times of the risk for ADR [33], and it has more 
importance than patient characteristics in the explanation of ADR 
[44]. To back up this, literature witnessed that about 5% of all hospital 
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admissions were due to ADR with an average length of hospital stay of 
1.8-8.5 days per patient per ADR. [45-48].
Age
Older age was reported as an independent predictor of ADR, evidenced 
only in one study [27], while other studies reported that age was 
not an independent predictor of ADR. This mismatch may be due 
to dissimilarities in matching criteria and demonstration of the 
significance of age as a risk factor only in univariate analysis. However, 
the incidence of ADRs was significantly higher in the elderly patients 
compared to other age groups [22,34,49,50], owing to increased age, 
deteriorating organ function, reduced hepatic and renal clearance, 
polymorbidity, polypharmacy, usage of over the counter drugs, and 
alternative medicine [34,51,52].
Renal impairment
It is widely accepted that renal impairment has a direct effect on a 
number of ADRs, and it was recognized first time in the year 1966 by 
the Smith et al. [53]. However, our review findings identified that it was 
an independent predictor of ADR in both adult patients and elderly 
patients [1,23,27,30]. The patients with renal impairment display 
altered drug clearance results that may ensue either drug toxicity or 
subtherapeutic effect. Hence, it is pretty much important for early 
estimation of creatinine clearance to identify the renal function, before 
prescription of such drugs having higher risk ADRs, particularly in 
elderly patients.
History of ADR
This review highlighted that history of ADR as a significant predictor 
in adult population which may be because of their active immunity 
compared to elderly patients. Two studies stated that patients with 
previously experienced ADRs were having 17.46 times odds of ADR 
in tuberculosis and 28.94 times odds in HIV/AIDs positive [22,23]. 
Prescriber’s attention toward medication and ADR history taking may 
reduce the recurrence of ADR in such vulnerable population.
Gender
Female gender was identified to be an independent predictor of ADR 
in the two articles [22,26], while one study revealed significance 
only through univariate logistic regression analysis [15]. However, 
further detailed research is required for a definite relationship. Few 
explanations behind the predisposition of women for ADR were 
attributed to them having lower lean body mass, reduction in hepatic 
clearance, differences in activity of cytochrome P450 (CYP) enzymes, 
and metabolization of drugs at different rates compared with men [54]. 
Moreover, females are known to use oral contraceptives, hormonal 
supplements adding on to increased number of drugs, especially in their 
reproductive years, and vitamin and mineral supplements during pre 
and postmenopausal periods that may predispose them for ADRs  [55]. 
However, few studies recommended that it was not a significant risk 
factor of ADR through their observations [35,56].
Strengths and limitations
Strength of the present review was strict inclusion criteria mandating 
assessment of risk factor with fitting statistical method and usage 
explicit definitions of ADR. The number of studies selected was low, as 
many studies did not mention true sample sizes had to be excluded. 
Many studies failed to give the appropriate explanation for their 
insignificance of risk factors. However, our quality assessment of each 
study was subjected to affirm the independent predictors of ADRs.
CONCLUSION
Review of literature found eleven papers that detailed the following 
measurable risk factors polypharmacy, comorbidities, length of stay, 
age, renal impairment, history of ADR, and gender linked with ADRs. 
Multiple drug regimen is the most frequently documented independent 
medication-related risk factor of ADR. Renal impairment had non-
discrimination in both adult and elderly patients with respect to 
their risk. Gender is an independent predictor of ADR evidenced in a 
negligible amount of studies; further, more research is required to find 
its definite relationship with ADR. Aging increases the risk of ADR in 
association with multiple diseases and number of drugs. There is a 
great significance for reevaluation of pharmacotherapy in the elderly 
patients to reduce the risk of drug-related issues. Researchers and 
health-care professionals should consider all the factors of drug-related 
issues for the rationale of treatment.
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